"10.1371_journal.pone.0108264","plos one","2014-09-26T00:00:00Z","Harriette R Mogul; Ruth Freeman; Khoa Nguyen; Michael Frey; Lee-Ann Klein; Sheila Jozak; Karen Tanenbaum","Department of Medicine, Division of Endocrinology, New York Medical College, Valhalla, New York, United States of America; Departments of Medicine and Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, New York, United States of America","Conceived and designed the experiments: HRM RF LK. Performed the experiments: HRM RF MF SJ KT LK. Analyzed the data: HRM RF MF KN. Contributed reagents/materials/analysis tools: HRM MF RF. Contributed to the writing of the manuscript: HRM RF LK KN.","EMPOWIR (NCT00618072) is an unsolicited, investigator-initiated study partly supported by Glaxo Smith Kline. The Rosiglitazone (trade name Avandia) used in this study is a Glaxo Smith Kline product. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","09","Harriette R Mogul","HRM",7,TRUE,3,6,4,NA,TRUE,TRUE,FALSE,0,NA,FALSE
